Scilliroside
Scilliroside is a cardiac glycoside, a type of compound that has a specific effect on the heart. It is found in certain species of plants, including those in the Scilla and Urginea genera.
Chemical Structure[edit]
Scilliroside is a steroidal cardiac glycoside. Its structure is characterized by a steroid nucleus, a lactone ring at the C-17 position, and a sugar moiety attached at the C-3 position. The steroid nucleus is responsible for the biological activity of the compound, while the sugar moiety and lactone ring can influence its solubility and potency.
Biological Activity[edit]
Scilliroside, like other cardiac glycosides, works by inhibiting the Na+/K+-ATPase enzyme. This inhibition leads to an increase in intracellular sodium levels, which then leads to an increase in intracellular calcium levels via the sodium-calcium exchanger. The increased calcium levels result in stronger heart contractions, making cardiac glycosides useful in treating certain heart conditions, such as congestive heart failure and atrial fibrillation.
However, due to their narrow therapeutic index and potential for toxicity, the use of cardiac glycosides, including scilliroside, is limited and they are typically reserved for cases where other treatments are ineffective.
Natural Sources[edit]
Scilliroside is found in certain species of plants in the Scilla and Urginea genera. These plants are native to Europe, Africa, and Asia, and have been used in traditional medicine for their cardiac effects. However, due to the potential for toxicity, their use requires careful dosage control.
Toxicity[edit]
The same mechanism that makes scilliroside effective in treating heart conditions can also lead to toxicity. Overdose can result in cardiac arrhythmias, electrolyte imbalances, and gastrointestinal symptoms such as nausea and vomiting. In severe cases, overdose can be fatal.
See Also[edit]
-
Scilliroside structure
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
